Siena Biotech S.p.A. Report issue

For profit Phase 2
Founded: Siena Italy (2000)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
2009
NCT01521832
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

sen0014196 (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Huntington Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 1